Timely adherence to follow-up after high-risk lung cancer screenings.
Sign Up to like & getrecommendations! Published in 2023 at "Journal of medical screening"
DOI: 10.1177/09691413231162507
Abstract: OBJECTIVE To achieve the lung cancer screening (LCS) mortality benefit in clinical trials, timely, real-world follow-up of abnormal test results is necessary. Presently, annual LCS rates are lower than in trials, and adherence to follow-up… read more here.
Keywords: lung cancer; adherence follow; timely adherence;